CTCAEskalan

The Common Terminology Criteria for Adverse Events (CTCAE) is a standardized system used to describe and grade the severity of adverse events in clinical trials. Developed by the National Cancer Institute (NCI), it provides a consistent language for reporting side effects, making it easier for researchers and healthcare providers to compare results across different studies. The CTCAE scale ranges from grade 1 (mild) to grade 5 (life-threatening), with each grade providing specific criteria for the severity of the adverse event. This system is widely used in oncology and other medical fields to ensure accurate and comparable reporting of adverse events, thereby enhancing the quality and reliability of clinical research.